Integra LifeSciences Reports First Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Integra LifeSciences (IART) Tops Q1 EPS by 6c
April 27, 2022 6:05 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.74, $0.06 better than the analyst estimate of $0.68. Revenue for the quarter came in at $376.6 million versus the consensus estimate of $362.04 million.
GUIDANCE:
Integra LifeSciences sees FY2022 EPS of $3.27-$3.35, versus the consensus of... More
